Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
| Promis Neurosciences Inc. | 1.750% | -2.247% | 11.538% | -76.644% | 74.874% | -73.874% | -82.530% |
| InMed Pharmaceuticals Inc. | 15.290% | -8.068% | -21.725% | -77.523% | -28.779% | -99.669% | -99.901% |
| Resverlogix Corp | - | 0.000% | 8.955% | -61.780% | -15.116% | -93.866% | -98.608% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat